In primary HCC samples, resected tumor samples, and HCC cell lines, the expression of SLAMF3 was significantly lower than in healthy cells, suggesting downregulation when hepatocytes undergo tumorigenesis. Here, LY9 is linked to hepatocellular carcinoma.